Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

Children with atopic diseases have a higher risk of developing alopecia areata.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Combining microdermabrasion with steroid injections improves hair regrowth in scalp alopecia areata.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

A woman with severe angioedema improved significantly after treatment with rituximab.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Most kids with alopecia areata have other health issues, often allergies or skin conditions.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Both microneedling and injections are equally effective for treating alopecia areata.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.